Literature DB >> 9344203

The immune response in halo nevi.

R A Zeff1, A Freitag, C M Grin, J M Grant-Kels.   

Abstract

The mechanism(s) responsible for halo nevus presents a provocative link with the immune response to melanoma. Although no direct demonstration of melanocyte killing has been observed by the immune effector cells found within the halo, the abundance of antigen-presenting cells in the regressing nevus and the presence of T lymphocytes at the site of depigmentation suggest that these cells participate in the halo phenomenon. Within the latter population of cells, evidence points to the involvement of CD8+ T cells as potential effectors in the destruction of nevomelanocytes. The break in tolerance that triggers migration and the presumed activation of these and other lymphocytes in the nevus in the apparent absence of disease remains unexplained. This brief overview reviews the evidence for the participation of the immune response in the genesis of the halo nevus.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9344203     DOI: 10.1016/s0190-9622(97)70181-6

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  18 in total

1.  Skin lesions with white rings.

Authors:  R P Usatine
Journal:  West J Med       Date:  1999-07

2.  Mechanisms of regression.

Authors:  Dirk M Elston
Journal:  Clin Med Res       Date:  2004-05

Review 3.  Melanoma-associated leukoderma - immunology in black and white?

Authors:  Hadas Prag Naveh; Uma N M Rao; Lisa H Butterfield
Journal:  Pigment Cell Melanoma Res       Date:  2013-10-09       Impact factor: 4.693

4.  Development of Halo Nevus Around Nevus Spilus as a Central Nevus, and the Concurrent Vitiligo.

Authors:  Yoon Young Kim; Mi Yeon Kim; Tae Yoon Kim
Journal:  Ann Dermatol       Date:  2008-12-31       Impact factor: 1.444

5.  The immunopathology of regression in benign lichenoid keratosis, keratoacanthoma and halo nevus.

Authors:  Ilene B Bayer-Garner; Doina Ivan; Mary R Schwartz; Jaime A Tschen
Journal:  Clin Med Res       Date:  2004-05

Review 6.  Melanocytic nevi and melanoma: unraveling a complex relationship.

Authors:  W E Damsky; M Bosenberg
Journal:  Oncogene       Date:  2017-06-12       Impact factor: 9.867

Review 7.  HLA antigen and NK cell activating ligand expression in malignant cells: a story of loss or acquisition.

Authors:  Michael Campoli; Soldano Ferrone
Journal:  Semin Immunopathol       Date:  2011-04-28       Impact factor: 9.623

8.  Involvement of interferon-gamma genetic variants and intercellular adhesion molecule-1 in onset and progression of generalized vitiligo.

Authors:  Mitesh Dwivedi; Naresh C Laddha; Kriti Shah; Bela J Shah; Rasheedunnisa Begum
Journal:  J Interferon Cytokine Res       Date:  2013-06-18       Impact factor: 2.607

9.  Clinical and dermoscopic stability and volatility of melanocytic nevi in a population-based cohort of children in Framingham school system.

Authors:  Alon Scope; Stephen W Dusza; Ashfaq A Marghoob; Jaya M Satagopan; Juliana Braga Casagrande Tavoloni; Estee L Psaty; Martin A Weinstock; Susan A Oliveria; Marilyn Bishop; Alan C Geller; Allan C Halpern
Journal:  J Invest Dermatol       Date:  2011-05-12       Impact factor: 8.551

10.  Regression of nevi in a melanoma patient treated with interferon.

Authors:  Ayelet Rishpon; Nir Nathanson
Journal:  Dermatol Pract Concept       Date:  2012-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.